Eledon Pharmaceuticals (ELDN) Treasury Shares (2014 - 2025)
Eledon Pharmaceuticals (ELDN) reported Treasury Shares of $336225.0 for Q4 2025, up 630.92% on a YoY basis from $46000.0 in Q4 2024, and up 630.92% quarter-over-quarter from $46000.0 in Q4 2024.
Eledon Pharmaceuticals (ELDN) Treasury Shares (2014 - 2025) Analysis & Trends
Eledon Pharmaceuticals has reported Treasury Shares for 8 years, with the latest figure at $336225.0 in Q4 2025.
- For the quarter ending Q4 2025, Treasury Shares rose 630.92% year-over-year to $336225.0; the trailing twelve-month figure through Dec 2025 stood at $336225.0 (up 630.92% YoY), and the FY2025 full-year result was $336225.0, up 630.92% from the prior year.
- Treasury Shares for Q4 2025 stood at $336225.0, up from $46000.0 in the prior quarter.
- The five-year high for Treasury Shares was $336225.0 in Q4 2025, with the low at $15000.0 in Q4 2022.
- Historically, Treasury Shares has averaged $104306.2 across 4 years, with a median of $33000.0 in 2021.
- Annual changes were most pronounced in 2022 — Treasury Shares dropped 25.0% — and 2025, when it surged 630.92%.
- Eledon Pharmaceuticals' Treasury Shares stood at $20000.0 in 2021, then retreated by 25.0% to $15000.0 in 2022, then surged by 206.67% to $46000.0 in 2024, then surged by 630.92% to $336225.0 in 2025.
- The last three Treasury Shares figures came in at $336225.0 (Q4 2025), $46000.0 (Q4 2024), and $15000.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Eledon Pharmaceuticals | 439.58 Mn | 223.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 336,225.00 |
| Dec 31, 2025 | 336,225.00 |
| Dec 31, 2024 | 46,000.00 |
| Dec 31, 2024 | 46,000.00 |
| Dec 31, 2022 | 15,000.00 |
| Dec 31, 2022 | 15,000.00 |
| Dec 31, 2021 | 20,000.00 |
| Dec 31, 2021 | 20,000.00 |
| Dec 31, 2019 | 3,056.00 |
| Dec 31, 2019 | 3,056.00 |
| Dec 31, 2018 | 4,358.00 |
| Dec 31, 2018 | 4,358.00 |
| Dec 31, 2015 | 40,953.00 |
| Dec 31, 2015 | 40,953.00 |
| Dec 31, 2014 | 54,604.00 |
| Dec 31, 2014 | 54,604.00 |